scispace - formally typeset
Z

Zhuang Liu

Researcher at Soochow University (Suzhou)

Publications -  649
Citations -  107700

Zhuang Liu is an academic researcher from Soochow University (Suzhou). The author has contributed to research in topics: Photothermal therapy & Medicine. The author has an hindex of 149, co-authored 535 publications receiving 87662 citations. Previous affiliations of Zhuang Liu include Suranaree University of Technology & Agilent Technologies.

Papers
More filters
Journal ArticleDOI

Catalase-Loaded TaOx Nanoshells as Bio-Nanoreactors Combining High-Z Element and Enzyme Delivery for Enhancing Radiotherapy.

TL;DR: A novel type of bio-nanoreactor with catalase loaded inside TaOx hollow nanoshells is fabricated via a mild one-step method to synergistically enhance the efficacy of cancer radiotherapy by both depositing radiation energy within the tumor and overcoming hypoxia-induced radiotherapy resistance.
Journal ArticleDOI

Protein microarrays with carbon nanotubes as multicolor Raman labels.

TL;DR: In this paper, the authors used functionalized, macromolecular single-walled carbon nanotubes (SWNTs) as multicolor Raman labels for highly sensitive, multiplexed protein detection in an arrayed format.
Journal ArticleDOI

Amplification of Tumor Oxidative Stresses with Liposomal Fenton Catalyst and Glutathione Inhibitor for Enhanced Cancer Chemotherapy and Radiotherapy

TL;DR: The concise fabrication of biocompatible BSO/GA-Fe(II)@liposome is presented as an effective adjuvant nanomedicine to promote clinically used conventional cancer chemotherapy and radiotherapy, by greatly amplifying the intratumoral oxidative stress.
Journal ArticleDOI

Smart Nanoreactors for pH-Responsive Tumor Homing, Mitochondria-Targeting, and Enhanced Photodynamic-Immunotherapy of Cancer.

TL;DR: A unique type of enzyme-encapsulated, photosensitizer-loaded hollow silica nanoparticles with rationally designed surface engineering as smart nanoreactors are designed, which show enhanced retention responding to the acidic tumor microenvironment and are able to further target mitochondria, the cellular organelle most sensitive to ROS.